Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway
Immediate reporting of chest X-rays from general practice will reduce the time to diagnosis of lung cancer.
London – Brent REC, 05/06/2017, ref: 17/LO/0870
Randomised; Interventional; Design type: Diagnosis, Process of Care, Imaging
Primary study design
Secondary study design
Randomised controlled trial
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Specialty: Health services and delivery research, Primary sub-specialty: Health Services and Delivery Research; UKCRC code/ Disease: Cancer/ Malignant neoplasms of respiratory and intrathoracic organs, Respiratory/ Other diseases of the respiratory system
Participants are randomly allocated to one of two groups using block randomisation at session (half day level).
Group 1: Participants receive immediate reporting of chest X-rays referred by general practice, with CT chest when indicated.
Group 2: Participants receive the standard level of care. This includes the routine reporting of chest X-rays referred by general practice.
Participants are followed up to see how long it takes to diagnose lung cancer or how long it took to be discharged from the lung cancer pathway and to evaluate the effectiveness of immediate reporting of chest X-rays by general practice.
Primary outcome measures
Time (in days) to decision to treat (with intermediate time points) for lung cancer or discharge from the lung cancer pathway is measured using patient records at the time where there is a decision to treat or to be discharged from the lung cancer pathway.
Secondary outcome measures
1. Number of CT scans requested is measured using the number of CT chest scans through Radiology Information System at study completion
2. Survival is measured using aggregate data from cancer waiting time reporting at six and 12 months
3. Emergency admissions are measured using data from cancer waiting time reporting at study completion
4. Performance status is measured using data from cancer waiting time reporting at time of decision to treat
5. Number of urgent respiratory cancer referrals are measured from respiratory department records at study completion
6. Relative accuracy and usefulness of chest X-rays reporting by radiographers and consultant radiologists are measured using index diagnosis of thoracic radiologist and/or CT chest within 2 weeks of chest X-ray
7. Number of first 2WW appointments with all radiology results measured using clinician recorded data at time of appointment
8. Cost-effectiveness is measured using QALYS (Quality adjusted life years) at study completion
9. Patient satisfaction is measured using patient questionnaires at two weeks after chest x-ray
Overall trial start date
Overall trial end date
Participant inclusion criteria
1. Patients referred for a chest X-ray from general practice
2. Over 16 years
Target number of participants
Planned Sample Size: 4000; UK Sample Size: 4000
Participant exclusion criteria
1. Active diagnosis of lung cancer
2. Aged under 16 years
3. Chest X-rays referrals from any other practitioner (Emergency Department, Inpatient, Outpatient)
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
Hometon University Hospital NHS Foundation Trust
Cancer Research UK
Funding Body Type
private sector organisation
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Trial protocol to be submitted for peer review August 2017. Final results planned publication in a high-impact peer reviewed journal June 2019.
IPD sharing statement:
The current data sharing plans for the current study are unknown and will be made available at a later date
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting